Logo image of AKCA

Akcea Therapeutics Inc (AKCA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AKCA -

18.17
+0.03 (+0.17%)
Last: 10/9/2020, 8:24:15 PM
18.15
-0.02 (-0.11%)
After Hours: 10/9/2020, 8:24:15 PM
No Fundamental Analysis report for AKCA not available.

Akcea Therapeutics Inc / AKCA FAQ

What is the fundamental rating for AKCA stock?

ChartMill assigns a fundamental rating of 5 / 10 to AKCA.


What is the valuation status for AKCA stock?

ChartMill assigns a valuation rating of 1 / 10 to Akcea Therapeutics Inc (AKCA). This can be considered as Overvalued.


What is the profitability of AKCA stock?

Akcea Therapeutics Inc (AKCA) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for AKCA stock?

The Earnings per Share (EPS) of Akcea Therapeutics Inc (AKCA) is expected to decline by -445.83% in the next year.


Is the dividend of Akcea Therapeutics Inc sustainable?

The dividend rating of Akcea Therapeutics Inc (AKCA) is 0 / 10 and the dividend payout ratio is 0%.